Mankind Pharma Ltd.

Research Mankind Pharma Ltd. (MANKIND.NS) on Bullrun: market cap INR 939.88B, P/E 46.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is INR 939.88B; P/E is 46.0.

Peer valuation comparison

Latest P/E is 46.04x versus a Healthcare sector median of 21.74x (111.8% above).

Latest P/E is 46.04x versus a India median of 34.43x (33.7% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18INR 939.88B46.0n/a2

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2 INR.

About Mankind Pharma Ltd.

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases.

Related stock research

India stocks India Healthcare stocks A-Z stock index

Other Healthcare stocks

Abbott India Ltd. (ABBOTINDIA.NS) Ajanta Pharmaceuticals Ltd. (AJANTPHARM.NS) Alkem Laboratories Ltd. (ALKEM.NS) Aurobindo Pharma Ltd. (AUROPHARMA.NS) Caplin Point Laboratories Ltd. (CAPLIPOINT.NS) Cipla Ltd. (CIPLA.NS) Cohance Lifesciences Ltd. (COHANCE.NS) Divi's Laboratories Ltd. (DIVISLAB.NS) Dr. Reddy's Laboratories Ltd. (DRREDDY.NS) Emcure Pharmaceuticals Ltd. (EMCURE.NS) Gland Pharma Ltd. (GLAND.NS) Glenmark Pharmaceuticals Ltd. (GLENMARK.NS)

Frequently asked questions

What is Mankind Pharma Ltd.'s market cap?

Mankind Pharma Ltd.'s market capitalization is INR 939.88B.

What is Mankind Pharma Ltd.'s P/E ratio?

Mankind Pharma Ltd.'s price-to-earnings (P/E) ratio is 46.0.

What does Mankind Pharma Ltd. do?

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases.